Daily Archives: Friday April 12th, 2024

Innovative Health Initiative-Funding source with emphasis on implementing innovative solutions

“Innovative Health Initiative” (IHI) is a funding source which may not be well known in the Deartment yet, possibly because the first call for proposals was launched in 2022. IHI is partially funded by the EU and partially by industry associations within the natural sciences (pharmaceutical industry, biotechnology, medical technology). The calls from IHI differ from those we primarily associate with the EU. There is a focus on innovation, but with an emphasis on implementation rather than innovation at low TRL levels. One of the main goals is to facilitate the transition from industry-derived innovations to application in healthcare services to achieve the transformation required in the healthcare services in the future. This is reflected in the calls, which have so far been relatively specific. For instance, one of last year’s calls focused on “Patient-centered blood sample collection to enable decentralized clinical trials and improve access to healthcare,” focusing on the use of already established methods for such blood sampling. It is a requirement, not just a strength, that partners from industry and/or public administration be involved in the projects, and it is often industry partners who initiate the consortium.

At the moment, IHI calls 6 and 7 are active, with deadlines approaching soon. Therefore, next year’s calls may be more relevant. Establishing a good consortium will be a comprehensive process. Joining as a partner in projects initiated by others can be a good approach. On IHI’s website, there is a tool for registering as a potential partner and building networks. Potential partners from Norway are considered interesting, but one should consider specific Norwegian issues, such as healthcare financing, in relation to relevant projects. Another tip is to become a member of relevant COST networks. Here, there are often potential partners interested in working towards EU-related applications. An overview of active COST actions can be found on the COST website: : https://www.cost.eu/

One final point is that IHI welcomes input regarding future calls, allowing stakeholders to influence future directions.

Day of Immunology

The Norwegian Society of Immunology (NSI) will celebrate this year’s Day of Immunology, a world-wide project aiming to present different aspects of immunology to the general public (http://www.dayofimmunology.org/). This year’s theme is “Immunity through the ages: Navigating the science of aging and immunology”, and it will be celebrate with a popular science seminar with invited speakers at Litteraturhuset in Oslo which will be streamed to Vilvite (big auditorium), Saturday the 27th of April, from 1100 to 1300.

The program is enclosed. The seminar is open to everyone (but will be in Norwegian). Welcome!

From breakthrough technologies to game changing innovation – EIC opportunities

When: 07 May 08:30 – 12:00
Where: Digital and The Research Council of Norway, Drammensveien 288, Lysaker

The EIC is Europe’s leading innovation program to identify, develop, and scale up breakthrough technologies and ground-breaking innovations. The EIC wants your breakthrough technology to reach the market and has tools ranging from research, through commercialization, to scaling. Few Norwegian researchers and companies apply for the EIC.

Researchers and companies that have applied for the EIC will share their stories. We will get information about EIC’s tools; Pathfinder, Transition and Accelerator.

There will be an introduction by EIC’s chairman, Michiel Scheffer.

This is a hybrid event. Those participating in the Research Council’s premises in Drammensveien 288 will be able to sign up for a free lunch after the event.

Those who will participate in person can book bilateral meetings with the EIC NCPs in the afternoon. Get in touch with Waqar Ahmed (Norwegian Research Council) or Eva Langslet (Innovation Norway) to arrange this.

This event is relevant for researchers, companies, TTO, research leaders, research and innovation administrators, EU advisors and innovation advisors.